JYVECTY Trademark

Trademark Overview


On Thursday, May 20, 2021, a trademark application was filed for JYVECTY with the United States Patent and Trademark Office. The USPTO has given the JYVECTY trademark a serial number of 90723583. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Wednesday, October 16, 2024. This trademark is owned by Pfizer Inc.. The JYVECTY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for the treatment of alopecia areata, vitiligo, irritable bowel disease, ulcerative colitis, Crohn's disease and rheumatoid arthritis
jyvecty

General Information


Serial Number90723583
Word MarkJYVECTY
Filing DateThursday, May 20, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateWednesday, October 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 8, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for the treatment of alopecia areata, vitiligo, irritable bowel disease, ulcerative colitis, Crohn's disease and rheumatoid arthritis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 17, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, May 24, 2021NEW APPLICATION ENTERED
Tuesday, August 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 1, 2022ASSIGNED TO EXAMINER
Wednesday, February 2, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 8, 2022PUBLISHED FOR OPPOSITION
Tuesday, March 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 3, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 28, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 17, 2022SOU TEAS EXTENSION RECEIVED
Monday, October 17, 2022SOU EXTENSION 1 FILED
Monday, October 17, 2022SOU EXTENSION 1 GRANTED
Wednesday, October 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 28, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 28, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 28, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 18, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, April 3, 2024SOU EXTENSION 4 FILED
Tuesday, April 18, 2023SOU EXTENSION 2 FILED
Tuesday, April 18, 2023SOU EXTENSION 2 GRANTED
Thursday, April 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 10, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, October 10, 2023SOU EXTENSION 3 FILED
Tuesday, October 10, 2023SOU EXTENSION 3 GRANTED
Thursday, October 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 3, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, April 3, 2024SOU EXTENSION 4 GRANTED
Wednesday, October 16, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, October 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 16, 2024SOU EXTENSION 5 GRANTED
Wednesday, October 16, 2024SOU EXTENSION 5 FILED
Thursday, April 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED